Purchase Order 36C26325P1000

Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 (VISN 23). The contract, designated as a TAVR (transcatheter aortic valve replacement) award, does not utilize a set-aside designation and was awarded on July 23, 2025, with an ultimate completion date of the same day. The place of performance is Minneapolis, Minnesota, and Edwards Lifesciences LLC will serve as the sole prime contractor on this award. This purchase order represents a continuation of the company's critical role in supplying specialized cardiovascular medical devices to the VA healthcare system, supporting veteran care across multiple service networks.

This contract aligns with Edwards Lifesciences LLC's extensive portfolio of federal awards to the VA, which primarily consist of firm fixed-price purchase orders for advanced heart valve technologies and surgical implants. The company's federal contracting history demonstrates consistent provision of highly specialized cardiac devices such as SAPIEN 3 transcatheter heart valves and related cardiovascular technologies, with individual purchase orders typically ranging from $11,000 to $102,000. Edwards Lifesciences LLC's recognition as a self-certified small disadvantaged business, combined with its sole-source supplier status for many of these specialized medical products, underscores its unique position in supporting the VA's cardiovascular care programs for the veteran population.